Research and Development

Clinical Trials Investment Investment Trends Innovation Clinical Programs Oncology Treatments AI in Healthcare Healthcare Companies Gene Therapy Product Pipeline Market Dynamics Chronic Diseases Vaccines Innovative Therapies Alzheimer's Disease Joint Ventures Therapies Product Commercialization Pricing Strategies Obesity Treatments Immunology IL-2 Fusion Proteins

7 ARTICLES

last mo.

Pfizer Raises 2026 Revenue Floor After Q2 Beat as Covid Sales Fall

Management pointed to stronger non‑Covid drug sales and the $10 billion Metsera deal as steps to offset weakening revenue from the vaccine plus antiviral Paxlovid.

7 ARTICLES

2mo ago

GSK Reports Q2 Beat and Unveils £1.9 Billion Savings Plan

3 ARTICLES

2mo ago

Scilex Signs Binding Term Sheet for $100 Million Equity Investment From iHolding

9 ARTICLES

3mo ago

AbbVie Strikes Trump Drug-Pricing Deal, Pledges $100 Billion, Wins 3-Year Tariff Reprieve

Research and Development

Pfizer Raises 2026 Revenue Floor After Q2 Beat as Covid Sales Fall

GSK Reports Q2 Beat and Unveils £1.9 Billion Savings Plan

Scilex Signs Binding Term Sheet for $100 Million Equity Investment From iHolding

U.S. Opens Section 301 Probe Into Germany's Drug Pricing

HCW Biologics Posts Surprise Q1 Profit on Trimmune Deal as Listing Risk Lingers

Pfizer Beats Q1 Forecasts as Newer Drugs Offset COVID Slide

AbbVie to Build $1.4 Billion Injectable-Medicines Campus in Durham, N.C.

AbbVie to Invest $380 Million in Two North Chicago API Plants

Vertex Heads Into Feb. 12 Earnings With Cautious Market After Mixed Year

AbbVie Strikes Trump Drug-Pricing Deal, Pledges $100 Billion, Wins 3-Year Tariff Reprieve